Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Grant or award SVP, CLO & Secretary acquired 65,000 shares (grant or award)
  2. 4 Grant or award SVP, CFO & Treasurer acquired 65,000 shares (grant or award)
  3. 4 Grant or award CEO and President acquired 239,500 shares (grant or award)
  4. 4 Grant or award Director acquired 44,919 shares (grant or award)
  5. 4 Grant or award Director acquired 11,229 shares (grant or award)
  6. 4 Grant or award Director acquired 10,231 shares (grant or award)
  7. 4 Grant or award Director acquired 3,743 shares (grant or award)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Director acquired 7,486 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 4 Shares withheld for taxes SVP, Chief Development Officer gave up 11,928 shares (to pay taxes)
  17. 4 Shares withheld for taxes SVP, Chief Medical Officer gave up 8,659 shares (to pay taxes)
  18. 4 Shares withheld for taxes SVP, General Counsel, Sec. gave up 20,175 shares (to pay taxes)
  19. 4 Shares withheld for taxes SVP, Chief Business Officer gave up 23,385 shares (to pay taxes)
  20. 4 Shares withheld for taxes CEO & President gave up 135,697 shares (to pay taxes)

Page 11 of 19 · 378 filings